These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28542532)

  • 1. Correction: Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    Jeong H; Baek SY; Kim SW; Eun YH; Kim IY; Kim H; Lee J; Koh EM; Cha HS
    PLoS One; 2017; 12(5):e0178309. PubMed ID: 28542532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: The high prevalence of myopia in Korean children with influence of parental refractive errors: The 2008-2012 Korean National Health and Nutrition Examination Survey.
    Lim DH; Han J; Chung TY; Kang S; Yim HW;
    PLoS One; 2018; 13(12):e0209876. PubMed ID: 30571755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Validity of U.S. Nutritional Surveillance: National Health and Nutrition Examination Survey Caloric Energy Intake Data, 1971-2010.
    Archer E; Hand GA; Blair SN
    PLoS One; 2013; 8(10):. PubMed ID: 29364967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Association of birth weight with corneal power in early adolescence: Results from the National Health and Nutrition Examination Survey (NHANES) 1999-2008.
    PLOS ONE Staff
    PLoS One; 2019; 14(2):e0213396. PubMed ID: 30817795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
    Crowson CS; Rollefstad S; Kitas GD; van Riel PL; Gabriel SE; Semb AG;
    PLoS One; 2017; 12(4):e0175605. PubMed ID: 28388688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis-A Meta-Analysis.
    Fisher A; Bassett K; Goel G; Stanely D; Brookhart MA; Freeman HJ; Wright JM; Dormuth CR
    PLoS One; 2017; 12(2):e0172646. PubMed ID: 28199406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis.
    Sung YK; Yoshida K; Prince FHM; Frits ML; Cho SK; Choe JY; Lee HS; Lee J; Lee SS; Yoo DH; Helfgott SM; Shadick NA; Weinblatt ME; Solomon DH; Bae SC
    PLoS One; 2019; 14(8):e0221314. PubMed ID: 31412077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Population-based dementia prediction model using Korean public health examination data: A cohort study.
    Park KM; Sung JM; Kim WJ; An SK; Namkoong K; Lee E; Chang HJ
    PLoS One; 2019; 14(11):e0225553. PubMed ID: 31725798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.
    Dargham SR; Zahirovic S; Hammoudeh M; Al Emadi S; Masri BK; Halabi H; Badsha H; Uthman I; Mahfoud ZR; Ashour H; El Haq WG; Bayoumy K; Kapiri M; Saxena R; Plenge RM; Kazkaz L; Arayssi T
    PLoS One; 2019; 14(3):e0214258. PubMed ID: 30883600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis.
    Yang B; Huang Z; Feng W; Wei W; Zhang J; Liao Y; Li L; Liu X; Wu Z; Cai B; Bai Y; Wang L
    PLoS One; 2017; 12(3):e0173531. PubMed ID: 28253339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Chronic Hepatitis C Virus Infection Is Associated with the Development of Rheumatoid Arthritis: A Nationwide Population-Based Study in Taiwan.
    Su FH; Wu CS; Sung FC; Chang SN; Su CT; Shieh YH; Yeh CC
    PLoS One; 2016; 11(11):e0166508. PubMed ID: 27829054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
    Tokai N; Yoshida S; Kotani T; Yoshikawa A; Kimura Y; Fujiki Y; Matsumura Y; Takeuchi T; Makino S; Arawaka S
    PLoS One; 2019; 14(1):e0211750. PubMed ID: 30699195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.
    Gomides APM; de Albuquerque CP; Santos ABV; Amorim RBC; Bértolo MB; Júnior PL; Santos IA; Giorgi RDN; Sacilotto NC; Radominski SC; Borghi FM; Guimarães MFBR; Pinto MRDC; Resende GG; Bonfiglioli KR; Silva HCD; Sauma MFLDC; Sauma ML; de Medeiros JB; Pereira IA; de Castro GRW; Brenol CV; Xavier RM; da Mota LMH; Pinheiro GDRC
    PLoS One; 2019; 14(4):e0215198. PubMed ID: 30947308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
    Pan Y; Norton S; Gwinnutt JM; Kearsley-Fleet L; Symmons DPM; Lunt M; Young A; ; Hyrich KL; Verstappen SMM
    PLoS One; 2020; 15(4):e0231481. PubMed ID: 32240271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study.
    Raknes G; Småbrekke L
    PLoS One; 2019; 14(10):e0223545. PubMed ID: 31574126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: (In)Visible illness: A photovoice study of the lived experience of self-managing rheumatoid arthritis.
    Donnelly S; Wilson AG; Mannan H; Dix C; Whitehill L; Kroll T
    PLoS One; 2021; 16(4):e0250451. PubMed ID: 33852646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis.
    Baghdadi LR
    PLoS One; 2020; 15(12):e0243960. PubMed ID: 33296441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
    Choi S; Lee KH
    PLoS One; 2018; 13(6):e0199468. PubMed ID: 29912956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
    Moots RJ; Xavier RM; Mok CC; Rahman MU; Tsai WC; Al-Maini MH; Pavelka K; Mahgoub E; Kotak S; Korth-Bradley J; Pedersen R; Mele L; Shen Q; Vlahos B
    PLoS One; 2017; 12(6):e0179308. PubMed ID: 28582423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction to Expression of Concern on: Functional Improvement of Regulatory T Cells from Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan.
    PLOS ONE Staff
    PLoS One; 2021; 16(3):e0249512. PubMed ID: 33780509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.